Skip to main content
Pharming Group N.V. (AMS:PHARM)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
1.361
+0.031 (2.33%)
Mar 9, 2026, 5:37 PM CET

Pharming Group Revenue

Pharming Group had revenue of $97.29M USD in the quarter ending September 30, 2025, with 29.98% growth. This brings the company's revenue in the last twelve months to $362.27M, up 26.78% year-over-year. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.

Revenue (ttm)
$362.27M
Revenue Growth
+26.78%
P/S Ratio
2.95
Revenue / Employee
$896.72K
Employees
404
Market Cap
911.25M EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024297.20M51.88M21.15%
Dec 31, 2023245.32M39.69M19.30%
Dec 31, 2022205.62M6.75M3.39%
Dec 31, 2021198.87M-13.30M-6.27%
Dec 31, 2020212.17M22.79M12.03%
Jan 1, 2020 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ferrari Group 355.25M
Wereldhave 215.86M
OCI N.V. 879.60M
Corbion 1.27B
Acomo 1.45B
AMG Critical Materials 1.45B
Fugro 1.85B
Flow Traders 480.50M
Revenue Rankings

Pharming Group News

More News